Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects With Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study.

NCT04333433 is registered in ClinicalTrials.gov with InnFocus Inc. as lead sponsor.

NCT NCT04333433
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04333433 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Concurrent Controlled, Open-Label, Multicenter Clinical Study to Assess the Long-Term Safety of the PRESERFLO® MicroShunt in Subjects With Primary Open-Angle Glaucoma Who Have Completed Participation in the INN-005 Randomized Controlled Study.
Lead sponsor
InnFocus Inc.
Phase
Observational
Overall status
Completed
Start date
May 22, 2020
Completion date
November 24, 2022
Enrollment
279 (actual)
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

primary open-angle glaucoma